Perrigo (PRGO) Stock Forecast, Price Target & Predictions
PRGO Stock Forecast
Perrigo stock forecast is as follows: an average price target of $46.00 (represents a 66.12% upside from PRGO’s last price of $27.69) and a rating consensus of 'Hold', based on 9 wall street analysts offering a 1-year stock forecast.
PRGO Price Target
The average price target for Perrigo (PRGO) is $46.00 based on 1-year price targets from 9 Wall Street analysts in the past 3 months, with a price target range of $54.00 to $36.00. This represents a potential 66.12% upside from PRGO's last price of $27.69.
PRGO Analyst Ratings
According to 9 Wall Street analysts, Perrigo's rating consensus is 'Hold'. The analyst rating breakdown for PRGO stock is 0 'Strong Buy' (0.00%), 4 'Buy' (44.44%), 5 'Hold' (55.56%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Perrigo Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Jun 13, 2024 | Korinne Wolmeyer | Piper Sandler | $36.00 | $27.84 | 29.31% | 30.01% |
Apr 08, 2024 | Korinne Wolmeyer | Piper Sandler | $39.00 | $31.40 | 24.20% | 40.85% |
Nov 17, 2023 | Korinne Wolfmeyer | Piper Sandler | $37.00 | $30.07 | 23.04% | 33.62% |
Sep 06, 2022 | Jacob Hughes | Wells Fargo | $54.00 | $36.74 | 46.98% | 95.02% |
May 04, 2022 | - | Raymond James | $48.00 | $32.76 | 46.54% | 73.35% |
The latest Perrigo stock forecast, released on Jun 13, 2024 by Korinne Wolmeyer from Piper Sandler, set a price target of $36.00, which represents a 29.31% increase from the stock price at the time of the forecast ($27.84), and a 30.01% increase from PRGO last price ($27.69).
Perrigo Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 1 | 3 |
Avg Price Target | - | $36.00 | $37.33 |
Last Closing Price | $27.69 | $27.69 | $27.69 |
Upside/Downside | -100.00% | 30.01% | 34.81% |
In the current month, the average price target of Perrigo stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Perrigo's last price of $27.69. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Jun 13, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Apr 08, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Oct 03, 2022 | Raymond James | Outperform | Outperform | Hold |
Sep 14, 2022 | Bernstein | - | Market Perform | Downgrade |
Sep 14, 2022 | Guggenheim | - | Neutral | Downgrade |
Sep 14, 2022 | B. Riley Securities | - | Buy | Initialise |
Sep 14, 2022 | Morgan Stanley | - | Equal-Weight | Downgrade |
Sep 14, 2022 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
Sep 14, 2022 | Jefferies | - | Hold | Downgrade |
Sep 14, 2022 | Argus Research | - | Buy | Upgrade |
Perrigo's last stock rating was published by Piper Sandler on Jun 13, 2024. The company gave PRGO a "Overweight" rating, the same as its previous rate.
Perrigo Financial Forecast
Perrigo Revenue Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $1.16B | $1.12B | $1.19B | $1.18B | $1.16B | $1.10B | $1.12B | $1.07B | $1.10B | $1.04B | $981.10M | $1.01B | $1.29B | $1.21B | $1.22B | $1.34B | $1.32B | $1.19B |
Avg Forecast | $1.29B | $1.23B | $1.16B | $1.20B | $1.25B | $1.18B | $1.11B | $1.14B | $1.20B | $1.13B | $1.10B | $1.09B | $1.17B | $1.20B | $1.18B | $1.17B | $1.20B | $1.14B | $1.06B | $1.06B | $1.10B | $1.05B | $1.02B | $1.02B | $1.32B | $1.24B | $1.23B | $1.34B | $1.31B | $1.20B |
High Forecast | $1.32B | $1.25B | $1.18B | $1.22B | $1.27B | $1.20B | $1.13B | $1.17B | $1.22B | $1.14B | $1.12B | $1.11B | $1.20B | $1.22B | $1.20B | $1.20B | $1.23B | $1.16B | $1.09B | $1.09B | $1.13B | $1.08B | $1.05B | $1.05B | $1.35B | $1.27B | $1.26B | $1.38B | $1.35B | $1.23B |
Low Forecast | $1.27B | $1.21B | $1.14B | $1.18B | $1.23B | $1.16B | $1.09B | $1.13B | $1.18B | $1.12B | $1.08B | $1.08B | $1.14B | $1.18B | $1.16B | $1.15B | $1.18B | $1.12B | $1.05B | $1.04B | $1.08B | $1.03B | $1.00B | $1.01B | $1.30B | $1.21B | $1.21B | $1.32B | $1.29B | $1.18B |
# Analysts | 2 | 2 | 2 | 2 | - | - | - | - | 1 | 3 | 1 | 1 | 3 | 2 | 2 | 2 | - | - | - | - | 1 | 1 | 1 | 1 | 9 | 15 | 8 | 10 | 7 | 10 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.98% | 0.94% | 1.01% | 1.01% | 0.96% | 0.96% | 1.05% | 1.02% | 1.01% | 0.99% | 0.96% | 0.99% | 0.98% | 0.98% | 0.99% | 1.00% | 1.01% | 0.99% |
Perrigo's average Quarter revenue forecast for Mar 24 based on 1 analysts is $1.09B, with a low forecast of $1.08B, and a high forecast of $1.11B. PRGO's average Quarter revenue forecast represents a -5.51% decrease compared to the company's last Quarter revenue of $1.16B (Dec 23).
Perrigo EBITDA Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 2 | 2 | - | - | - | - | 1 | 3 | 1 | 1 | 3 | 2 | 2 | 2 | - | - | - | - | 1 | 1 | 1 | 1 | 9 | 15 | 8 | 10 | 7 | 10 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-15.50M | $184.10M | $56.80M | $140.10M | $134.00M | $144.70M | $32.30M | $95.90M | $91.30M | $488.30M | $3.60M | $174.70M | $-80.70M | $3.20M | $199.90M | $238.00M | $68.80M | $199.30M |
Avg Forecast | $241.78M | $230.06M | $216.89M | $224.27M | $233.24M | $220.75M | $208.39M | $214.31M | $224.64M | $212.46M | $205.73M | $154.10M | $220.06M | $224.85M | $221.20M | $140.09M | $224.99M | $701.25M | $199.42M | $110.74M | $205.91M | $196.97M | $190.64M | $196.15M | $246.97M | $231.42M | $230.47M | $212.58M | $245.47M | $224.47M |
High Forecast | $246.61M | $234.65M | $221.22M | $228.75M | $237.90M | $225.16M | $212.55M | $218.59M | $229.13M | $214.35M | $209.84M | $184.92M | $225.61M | $229.34M | $225.62M | $168.11M | $229.49M | $841.50M | $204.91M | $132.89M | $211.58M | $202.40M | $195.90M | $235.39M | $253.78M | $237.79M | $236.82M | $255.10M | $252.23M | $230.65M |
Low Forecast | $237.87M | $226.34M | $213.39M | $220.65M | $229.47M | $217.18M | $205.02M | $210.84M | $221.01M | $209.02M | $202.40M | $123.28M | $212.66M | $221.21M | $217.62M | $112.07M | $221.35M | $561.00M | $196.06M | $88.59M | $202.44M | $193.65M | $187.43M | $156.92M | $242.81M | $227.52M | $226.59M | $170.07M | $241.33M | $220.68M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -0.07% | 0.82% | 0.26% | 1.00% | 0.60% | 0.21% | 0.16% | 0.87% | 0.44% | 2.48% | 0.02% | 0.89% | -0.33% | 0.01% | 0.87% | 1.12% | 0.28% | 0.89% |
3 analysts predict PRGO's average Quarter EBITDA for Dec 23 to be $220.06M, with a high of $225.61M and a low of $212.66M. This is 19.53% upper than Perrigo's previous annual EBITDA (Sep 23) of $184.10M.
Perrigo Net Income Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 2 | 2 | - | - | - | - | 1 | 3 | 1 | 1 | 3 | 2 | 2 | 2 | - | - | - | - | 1 | 1 | 1 | 1 | 9 | 15 | 8 | 10 | 7 | 10 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-32.30M | $14.20M | $8.40M | $-1.10M | $-12.70M | $-52.10M | $-64.90M | $-1.30M | $32.10M | $-53.90M | $-111.90M | $2.80M | $-175.00M | $-154.60M | $60.60M | $106.40M | $-19.00M | $92.20M |
Avg Forecast | $130.25M | $122.02M | $112.42M | $113.79M | $120.65M | $109.68M | $101.45M | $102.83M | $124.82M | $115.06M | $64.93M | $-4.06M | $113.79M | $85.87M | $70.09M | $-3.69M | $96.66M | $-83.43M | $60.32M | $-2.91M | $77.23M | $89.57M | $81.92M | $42.78M | $137.44M | $115.34M | $120.48M | $95.04M | $146.56M | $127.13M |
High Forecast | $133.63M | $125.19M | $115.34M | $116.75M | $123.78M | $112.53M | $104.09M | $105.50M | $128.06M | $116.43M | $66.62M | $-3.24M | $116.53M | $88.10M | $71.91M | $-2.95M | $99.17M | $-66.74M | $62.48M | $-2.33M | $80.00M | $92.78M | $84.85M | $51.33M | $142.37M | $119.47M | $124.79M | $114.04M | $151.81M | $131.68M |
Low Forecast | $127.51M | $119.46M | $110.06M | $111.40M | $118.11M | $107.38M | $99.32M | $100.66M | $122.19M | $113.69M | $63.57M | $-4.87M | $106.94M | $84.07M | $68.62M | $-4.42M | $94.63M | $-100.12M | $59.00M | $-3.50M | $75.54M | $87.61M | $80.12M | $34.22M | $134.43M | $112.81M | $117.84M | $76.03M | $143.35M | $124.34M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -0.28% | 0.17% | 0.12% | 0.30% | -0.13% | 0.62% | -1.08% | 0.45% | 0.42% | -0.60% | -1.37% | 0.07% | -1.27% | -1.34% | 0.50% | 1.12% | -0.13% | 0.73% |
Perrigo's average Quarter net income forecast for Dec 23 is $113.79M, with a range of $106.94M to $116.53M. PRGO's average Quarter net income forecast represents a 701.36% increase compared to the company's last Quarter net income of $14.20M (Sep 23).
Perrigo SG&A Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 2 | 2 | - | - | - | - | 1 | 3 | 1 | 1 | 3 | 2 | 2 | 2 | - | - | - | - | 1 | 1 | 1 | 1 | 9 | 15 | 8 | 10 | 7 | 10 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $152.50M | $304.00M | $171.10M | $331.50M | $308.60M | $281.00M | $338.10M | $282.30M | $269.30M | $283.60M | $274.30M | $284.20M | $330.00M | $281.00M | $270.00M | $294.50M | $288.60M | $289.40M |
Avg Forecast | $332.37M | $316.26M | $298.16M | $308.30M | $320.63M | $303.46M | $286.47M | $294.60M | $308.81M | $292.06M | $282.81M | $477.00M | $302.52M | $309.09M | $304.08M | $433.63M | $309.29M | $407.95M | $274.14M | $342.79M | $283.06M | $270.77M | $262.08M | $319.10M | $339.51M | $318.12M | $316.83M | $261.71M | $337.45M | $308.57M |
High Forecast | $339.02M | $322.58M | $304.11M | $314.46M | $327.04M | $309.52M | $292.19M | $300.49M | $314.98M | $294.67M | $288.46M | $572.40M | $310.14M | $315.27M | $310.15M | $520.36M | $315.47M | $489.54M | $281.69M | $411.35M | $290.86M | $278.24M | $269.30M | $382.92M | $348.86M | $326.89M | $325.56M | $314.05M | $346.74M | $317.07M |
Low Forecast | $327.00M | $311.15M | $293.34M | $303.32M | $315.45M | $298.56M | $281.84M | $289.84M | $303.82M | $287.34M | $278.24M | $381.60M | $292.35M | $304.10M | $299.16M | $346.91M | $304.29M | $326.36M | $269.52M | $274.23M | $278.29M | $266.21M | $257.66M | $255.28M | $333.79M | $312.76M | $311.49M | $209.37M | $331.76M | $303.37M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.50% | 0.98% | 0.56% | 0.76% | 1.00% | 0.69% | 1.23% | 0.82% | 0.95% | 1.05% | 1.05% | 0.89% | 0.97% | 0.88% | 0.85% | 1.13% | 0.86% | 0.94% |
Perrigo's average Quarter SG&A projection for Mar 24 is $477.00M, based on 1 Wall Street analysts, with a range of $381.60M to $572.40M. The forecast indicates a 212.78% rise compared to PRGO last annual SG&A of $152.50M (Dec 23).
Perrigo EPS Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 2 | 2 | - | - | - | - | 1 | 3 | 1 | 1 | 3 | 2 | 2 | 2 | - | - | - | - | 1 | 1 | 1 | 1 | 9 | 15 | 8 | 10 | 7 | 10 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.24 | $0.10 | $0.06 | $-0.01 | $-0.09 | $-0.39 | $-0.48 | $-0.01 | $0.24 | $-0.40 | $-0.84 | $0.29 | $-1.29 | $-1.13 | $0.44 | $0.78 | $-0.14 | $0.68 |
Avg Forecast | $0.95 | $0.89 | $0.82 | $0.83 | $0.88 | $0.80 | $0.74 | $0.75 | $0.91 | $0.84 | $0.47 | $0.23 | $0.83 | $0.63 | $0.51 | $0.43 | $0.70 | $0.67 | $0.44 | $0.42 | $0.56 | $0.65 | $0.60 | $0.57 | $1.00 | $0.84 | $0.88 | $1.03 | $1.07 | $0.93 |
High Forecast | $0.97 | $0.91 | $0.84 | $0.85 | $0.90 | $0.82 | $0.76 | $0.77 | $0.93 | $0.85 | $0.49 | $0.24 | $0.85 | $0.64 | $0.52 | $0.44 | $0.72 | $0.69 | $0.46 | $0.44 | $0.58 | $0.68 | $0.62 | $0.59 | $1.04 | $0.87 | $0.91 | $1.07 | $1.11 | $0.96 |
Low Forecast | $0.93 | $0.87 | $0.80 | $0.81 | $0.86 | $0.78 | $0.72 | $0.73 | $0.89 | $0.83 | $0.46 | $0.23 | $0.78 | $0.61 | $0.50 | $0.42 | $0.69 | $0.65 | $0.43 | $0.41 | $0.55 | $0.64 | $0.58 | $0.55 | $0.98 | $0.82 | $0.86 | $1.01 | $1.05 | $0.91 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -0.29% | 0.16% | 0.12% | -0.02% | -0.13% | -0.58% | -1.09% | -0.02% | 0.43% | -0.61% | -1.41% | 0.51% | -1.29% | -1.34% | 0.50% | 0.76% | -0.13% | 0.73% |
According to 3 Wall Street analysts, Perrigo's projected average Quarter EPS for Dec 23 is $0.83, with a low estimate of $0.78 and a high estimate of $0.85. This represents a 730.00% increase compared to PRGO previous annual EPS of $0.10 (Sep 23).
Perrigo Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
PCRX | Pacira BioSciences | $13.85 | $43.00 | 210.47% | Hold |
ELAN | Elanco Animal Health | $15.09 | $25.83 | 71.17% | Buy |
PRGO | Perrigo Company | $27.69 | $46.00 | 66.12% | Hold |
AMPH | Amphastar Pharmaceuticals | $45.38 | $66.00 | 45.44% | Buy |
ANIP | ANI Pharmaceuticals | $60.51 | $71.00 | 17.34% | Buy |
COLL | Collegium Pharmaceutical | $37.19 | $41.50 | 11.59% | Buy |
PBH | Prestige Consumer Healthcare | $74.34 | $82.00 | 10.30% | Buy |
DCPH | Deciphera Pharmaceuticals | $25.59 | $26.32 | 2.85% | Hold |
PAHC | Phibro Animal Health | $19.46 | $18.67 | -4.06% | Buy |
PRGO Forecast FAQ
Is Perrigo a good buy?
No, according to 9 Wall Street analysts, Perrigo (PRGO) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 4 'Buy' recommendations, accounting for 44.44% of PRGO's total ratings.
What is PRGO's price target?
Perrigo (PRGO) average price target is $46 with a range of $36 to $54, implying a 66.12% from its last price of $27.69. The data is based on 9 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Perrigo stock go up soon?
According to Wall Street analysts' prediction for PRGO stock, the company can go up by 66.12% (from the last price of $27.69 to the average price target of $46), up by 95.02% based on the highest stock price target, and up by 30.01% based on the lowest stock price target.
Can Perrigo stock reach $40?
PRGO's average twelve months analyst stock price target of $46 supports the claim that Perrigo can reach $40 in the near future.
What are Perrigo's analysts' financial forecasts?
Perrigo's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $4.68B (high $4.77B, low $4.61B), average EBITDA is $876.68M (high $894.2M, low $862.51M), average net income is $434.61M (high $445.9M, low $425.47M), average SG&A $1.21B (high $1.23B, low $1.19B), and average EPS is $3.17 (high $3.25, low $3.1). PRGO's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $4.87B (high $4.97B, low $4.8B), average EBITDA is $913M (high $931.24M, low $898.24M), average net income is $478.48M (high $490.91M, low $468.43M), average SG&A $1.26B (high $1.28B, low $1.23B), and average EPS is $3.49 (high $3.58, low $3.42).
Did the PRGO's actual financial results beat the analysts' financial forecasts?
Based on Perrigo's last annual report (Dec 2023), the company's revenue was $4.66B, which missed the average analysts forecast of $4.73B by -1.54%. Apple's EBITDA was $151.9M, missing the average prediction of $806.19M by -81.16%. The company's net income was $-12.7M, missing the average estimation of $266.07M by -104.77%. Apple's SG&A was $641.8M, missing the average forecast of $1.35B by -52.44%. Lastly, the company's EPS was $-0.0939, missing the average prediction of $2.4 by -103.92%. In terms of the last quarterly report (Dec 2023), Perrigo's revenue was $1.16B, missing the average analysts' forecast of $1.17B by -1.53%. The company's EBITDA was $-15.5M, missing the average prediction of $220.06M by -107.04%. Perrigo's net income was $-32.3M, missing the average estimation of $113.79M by -128.38%. The company's SG&A was $152.5M, missing the average forecast of $302.52M by -49.59%. Lastly, the company's EPS was $-0.24, missing the average prediction of $0.83 by -128.92%